NCT04179136View on ClinicalTrials.gov

The Role of Gut Microbiome on Cardiovascular Health Benefits of Dietary Lignans (CardioFlax Study).

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

November 25, 2019

Primary Completion Date

July 30, 2021

Study Completion Date

July 30, 2021

Conditions
Healthy Volunteers
Interventions
DIETARY_SUPPLEMENT

lignan capsules contain 300 mg flaxseed (SDG) extract

lignan capsules contain 300 mg flaxseed (SDG) extract

DIETARY_SUPPLEMENT

Placebo treatment matching intervention

Placebo treatment matching intervention

Trial Locations (1)

SE1 9NH

King's College London, London

All Listed Sponsors
lead

King's College London

OTHER

NCT04179136 - The Role of Gut Microbiome on Cardiovascular Health Benefits of Dietary Lignans (CardioFlax Study). | Biotech Hunter | Biotech Hunter